Story · Medicine & Biotech · Mind & Brain
Evidence-Based Therapeutic Strategies for Degenerative Neurocognitive Decline in Early Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials
1 outlet · first reported by Cureus on
The early stages of Alzheimer’s disease (AD) consist of mild cognitive impairment (MCI) from AD and mild AD dementia. The early stages offer a crucial opportunity for intervention to reduce cognitive and functional decline. In the last decade, multiple disease-modifying and non-pharmacological… (Cureus)
Coverage, in order
-
Evidence-Based Therapeutic Strategies for Degenerative Neurocognitive Decline in Early Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials
The early stages of Alzheimer’s disease (AD) consist of mild cognitive impairment (MCI) from AD and mild AD dementia. The early stages offer a crucial opportunity for intervention to reduce cognitive and functional decline. In the last decade, multiple disease-modifying and non-pharmacological…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.